logo
Plus   Neg
Share
Email

Alexion Pharma Raises 2019 Outlook

Alexion Pharmaceuticals Inc. (ALXN) increased its revenues and earnings per share guidance for fiscal year 2019.

The company raised its fiscal year 2019 earnings per share outlook to a range of $8.58 to $8.78 from the prior estimation of $8.13 to $8.41 per share. It also increased its non-GAAP earnings per share guidance to a range of $10.25 to $10.40 from the previous outlook of $9.65 to $9.85 per share. Analysts polled by Thomson Reuters expect the company to report earnings of $9.94 per share for fiscal year 2019. Analysts' estimates typically exclude special items.

The company now projects total revenues for fiscal year 2019 to be $4.860 billion to $4.890 billion, compared to the prior outlook of $4.750 billion to $4.800 billion. Analysts expect revenues of $4.85 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp. (INTC), the world's biggest chipmaker, Thursday said its profit and revenues for the fourth quarter trumped Wall Street estimates. The company's shares gained nearly 7 percent driven by strong outlook for the first quarter and full year 2020. Santa Clara, California-based Intel reported... ABH Pharma, Inc. and Stocknutra.com Inc. have recalled all of its dietary supplement products pursuant to a consent decree entered by the U.S. District Court for the Eastern District of New York. The companies have recalled all dietary supplement products manufactured and sold between January 2013... New York-based grocery chain Fairway Market has filed for Chapter 11 bankruptcy protection, but said its stores will remain open across the Tri-State area during the court process and it does not expect any service interruptions. This is the second time the company has filed for bankruptcy. The company earlier filed for Chapter 11 bankruptcy protection in 2016.
Follow RTT
>